EW
- Edwards Lifesciences Corporation
()
Overview
Company Summary
Edwards Lifesciences Corporation (EW) is a global medical technology company that specializes in the development, manufacturing, and commercialization of innovative devices and solutions for patients with structural heart disease and critical care monitoring.
The company primarily focuses on three major areas: transcatheter heart valves, surgical heart valves, and critical care monitoring.
In the transcatheter heart valves segment, Edwards Lifesciences produces minimally invasive devices that are used to replace a patient's native heart valves without needing open-heart surgery. These valves are delivered to the heart through catheters and offer a less invasive treatment option compared to traditional surgical valve replacement.
In the surgical heart valves segment, Edwards Lifesciences manufactures durable mechanical heart valves and tissue heart valves that are used in open-heart surgeries. These surgical valves are designed to address various conditions requiring valve replacement, such as aortic or mitral valve diseases.
Additionally, the company provides critical care monitoring solutions that enable healthcare professionals to accurately measure a patient's hemodynamic status in intensive care units. These monitoring systems assist in improved patient management and help healthcare providers make informed decisions regarding patient treatment and recovery.
Overall, Edwards Lifesciences Corporation plays a crucial role in the healthcare industry by offering a range of advanced medical devices and solutions to enhance patient outcomes in the areas of structural heart disease and critical care monitoring.